📰 Parallel Group Study News
Parallel Group Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Parallel Group Study. Real-time updates on events, politics, business and more.
September 18, 2023
You’ve probably heard about SuperGreen TONIK. Read the 2023 review to find out whether it’s worth the hype and what you stand to gain from it.
July 24, 2023
New anti-amyloid monoclonal antibody drugs for Alzheimer disease have produced encouraging results in targeting the accumulation of amyloid beta plaques; however, questions remain regarding the risk-benefit profile and cost implications.
March 17, 2023
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) as part of the 2023...
August 4, 2022
Transferred anti-IL 18 monoclonal antibody product to Apollo Therapeutics in July with the approximate $15 million of upfront payment received in AugustDosed first patient in the Phase 2 PEAK... | August 4, 2022
December 29, 2021
Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of Pediatric Crohn’s Disease - read this article along with other careers information, tips and advice on BioSpace
December 17, 2021
You’ve probably heard about SuperGreen TONIK 2021. Read on to find out whether it’s worth the hype and what you stand to gain fro